A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.
Lucknow: A simple blood test every three months could save the lives of Chronic Obstructive Pulmonary Disease (COPD) patients ...
C hronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition—primarily chronic bronchitis and ...
For decades, inhalers have been the cornerstone of COPD care. They improve symptoms and prolong life. But adherence is low — ...
Women face a higher risk of lung damage compared to men, even if they have never smoked. Research shows that biological ...
To understand the hidden dimensions of COPD among non-smokers, The Week spoke with pulmonologist Dr Shahid Patel, consultant ...
Environmental sustainability begins in the clinic, Emily Sbiroli, MD, an emergency medicine physician with San Ysidro Health ...
Yesterday, the American Lung Association delivered detailed comments from 16 health organizations, as well as comments signed by 968 members of the public, to urge the Environmental Protection Agency ...
Discover why Regeneron (REGN) is a top investment pick with strong Dupixent growth, a robust pipeline, and lasting potential.
Fragranced consumer products emit volatile organic compounds that form nanoparticles, contributing to indoor air pollution ...
Our mission is to transform seven billion smartphones into guardians of lung health. To accelerate this vision, we are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback